Neutralizing response against SARS-CoV-2 Omicron BA.5 and XBB.1.5 in hemodialysis patients.

"CONFLICT OF INTEREST STATEMENT F.K. is listed as inventor on patent application on SARS-CoV-2 neutralizing antibodies filed by the University of Cologne. The other authors have no conflicts of interest to declare."

"FUNDING F.C.K. is supported by the Cologne Clinician Scientist Program (CCSP)/Faculty of Medicine/University of Cologne. Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (Project No. 413543196) and reports grants from Else Kröner-Fresenius-Stiftung, grants from German Research Foundation under Germany's Excellence Strategy—EXC 2030: CECAD—Excellent in Aging Research—Project number 390661388, grants from Koeln Fortune program/Faculty of Medicine, University of Cologne, outside the submitted work. R.-U.M. is supported by the DFG (grants MU 3629/6-1, CRU329, DI 1501/9 as well as under Germany's Excellence Strategy—CECAD, EXC 2030–390661388), the PKD Foundation and the Marga and Walter Boll-Foundation. F.K. is supported by COVIM: NaFoUniMedCovid19 (FKZ:01KX2021) and the German Center for Infection Research. P.A. is supported by the German Center for Infection Research."